Patrick Heron

Patrick Heron

Direttore/Membro del Consiglio presso ARCUTIS BIOTHERAPEUTICS, INC.

Patrimonio netto: 2 M $ in data 30/06/2026

55 anni
Health Technology
Commercial Services
Finance

Profilo

Mr. Patrick J.
Heron
is a Lead Independent Director at MBX Biosciences, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., an Independent Director at Arcutis Biotherapeutics, Inc. and a Managing Partner at Frazier Management LLC.
He is on the Board of Directors at MBX Biosciences, Inc., Mirum Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., VentiRx Pharmaceuticals, Inc., Zavante Therapeutics, Inc. and Calibrium LLC.
Mr. Heron was previously employed as an Independent Director by HilleVax, Inc., an Independent Non-Executive Director by Passage Bio, Inc., a Chairman by Scout Bio, Inc., an Independent Director by Vaxcyte, Inc., an Independent Director by Iterum Therapeutics Plc, an Independent Director by Tobira Therapeutics, Inc., an Independent Director by Imago BioSciences, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Tobira Therapeutics, Inc. /Old/, an Engagement Manager by McKinsey & Co., Inc., a Principal by Cetus Corp., a Chairman by Kalidex Pharmaceuticals, Inc., and a Principal by The General Hospital Corp.
He also served on the board at SanReno Therapeutics, Silvergate Pharmaceuticals, Inc., Calixa Therapeutics, Inc., Marcadia Biotech, Inc., Cerexa, Inc., Trubion Pharmaceuticals, Inc., MedPointe, Inc., QuatRx Pharmaceuticals Co., Amunix, Inc., ARMO Biosciences, Inc., Avera Pharmaceuticals, Inc., Chimerix, Inc., Ignyta, Inc., Informed Medical Communications, Inc., Moximed, Inc., Panomics LLC, PreCision Dermatology, Inc. and Recida Therapeutics, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard Business School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/06/2026 32.213 ( 0,03% ) 844 625 $ 30/06/2026
15/06/2026 5.703 ( 0,01% ) 667 650 $ 30/06/2026
0,03%
31/01/2025 9.110 ( 0,03% ) 614 925 $ 30/06/2026
0,02%
01/11/2025 14.937 ( 0,02% ) 162 066 $ 30/06/2026
04/06/2026 0 ( -.--% ) - $ 30/06/2026

Posizioni attive di Patrick Heron

SocietàPosizioneInizio
ARCUTIS BIOTHERAPEUTICS, INC. Direttore/Membro del Consiglio -
MIRUM PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 07/11/2018
MBX BIOSCIENCES, INC. Direttore/Membro del Consiglio 01/07/2020
Investitore di Private Equity 01/08/1999
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Patrick Heron

SocietàPosizioneFine
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Patrick Heron

Formazione di Patrick Heron

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

75

Relazioni di 1° grado

45

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private45

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Patrick Heron